Genflow Biosciences SRL
Genflow Biosciences reported total assets of €3.74m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Genflow Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +175 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Genflow Biosciences's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −267,932 € | ||||
| Equity | 896,515 € | ||||
| Cash | 27,082 € | ||||
| EBITDA | −266,473 € | ||||
| Total assets | €3.74m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 01 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 07 Aug 2023
- Year ended 31 Dec 2021filed on 12 Sep 2022
Genflow Biosciences's financial analysis
- Solvency24.0%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Genflow Biosciences
Genflow Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0753.904.685
- VAT number
- BE0753904685
- Peppol
- Registered · 0208:0753904685 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Sep 2020
- Registered office
- 6041 Charleroi
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Genflow Biosciences (SRL) has been based in Charleroi since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 267,932 € and equity of 896,515 €; its revenue is not published. Its solvency stands at 24.0%, below the median of its sector (57.9%).
Companies similar to Genflow Biosciences
Companies in the same business, of comparable size and area, outside its group.
- ExeVir Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.76m
- Tanai Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.87m
- XomeXBio Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.50m
- Wishbone Research and experimental development on natural sciences and engineering Flémalle · balance sheet €3.39m
- Ipratech Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.29m
- BIO-Sourcing Research and experimental development on natural sciences and engineering Liège · balance sheet €6.59m
- Amyl Therapeutics Research and experimental development on natural sciences and engineering Liège · balance sheet €7.02m
- Bioxodes Research and experimental development on natural sciences and engineering Charleroi · balance sheet €7.68m
Frequently asked questions about Genflow Biosciences
What is the revenue of Genflow Biosciences?
Genflow Biosciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Genflow Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0753904685 for Genflow Biosciences, if the company is VAT-registered. Its company number (CBE) is 0753.904.685.
Where is the registered office of Genflow Biosciences?
According to the CBE register, the registered office of Genflow Biosciences is in 6041 Charleroi.
What is the equity of Genflow Biosciences?
At the close of the 2025 financial year, the equity of Genflow Biosciences amounts to 896,515 €, a solvency of 24.0% of total assets.
Who manages Genflow Biosciences?
The register lists 1 active mandates at Genflow Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Genflow Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →